Skip to main content

Select Drug Profiles

Cosela First CDK4/6 Inhibitor FDA Approved to Reduce Chemotherapy-Induced Myelosuppression

Vyxeos Now Indicated for Treatment of Pediatric Patients with AML

FDA Approvals, Lymphoma

FDA Approved Ukoniq, New Targeted Therapy, for Marginal-Zone and Follicular Lymphoma

FDA Approvals, Lymphoma

FDA Approved Breyanzi, Novel CAR T-Cell Therapy, for Large B-Cell Lymphoma

FDA Approvals, Multiple Myeloma, Oncology

FDA Approved Pepaxto for Relapsed or Refractory Multiple Myeloma

FDA Approvals, Multiple Myeloma, Oncology

FDA Approved Abecma, First CAR T-Cell Therapy for Multiple Myeloma

Achieving Improved Outcomes Through Partnerships Between Optometrists and Retina Specialists

Leading Population Health Efforts: The Power of Vowels

Richard G. Stefanacci, DO, MGH, MBA, AGSF, Anindita Banerjee, BSc, MBA

Richard G. Stefanacci, DO, MGH, MBA, AGSF; Anindita Banerjee, BSc, MBA

A Call for Innovation: We Need to Go Off Road to Ensure Medication Adherence Amid COVID-19

Javier Gonzalez, PharmD

Javier Gonzalez, PharmD

What Is Your IQ(VIA)?

David B. Nash, MD, MBA

David B. Nash, MD, MBA

Page 24 of 244
Results 231 - 240 of 2438